摘要
以3-氧代戊二酸二酯、N,N-二甲基甲酰胺二甲基缩醛(DMF-DMA)、伯胺为原料,L-脯氨酸为催化剂,多组分一步构建了以4-羟基-2-吡啶酮为母核的一系列化合物,并通过核磁、高分辨质谱等确证了其结构.该方法操作简便,无需中间体的分离,为4-羟基-2-吡啶酮类化合物的合成提供了便捷的方法,且溶剂参与反应,从而丰富了母体5位取代基的多样性.
A series of 4-hydroxyl-2-pyridone derivatives were synthesized via a one-pot and multicomponent reaction of dimethyl 3-oxopentanedioate, N,N-dimethylformamide dimethyl acetal(DMF-DMA) and primary amine in aliphatic alcohol by using L-proline as catalyst. The structures of these compounds were confirmed by NMR and HRMS. This work provides a convenient method for construction of pyridones with the advantages of operation simplicity, free of isolating intermediates etc. Moreover, the participation of solvent in the reaction enriched the diversity of 5-substitution in the pyridone backbone.
引文
[1]Tang,Y.;Li,J.;Zhao,S.Y.Chin.J.Org.Chem.2011,31,9(in Chinese).(唐玉敏,李晶,赵圣印,有机化学,2011,31,9.)
[2]Jessen,H.J.;Gademann,K.Nat.Prod.Rep.2010,27,1168.
[3]Ando,K.;Matsuura,I.;Nawata,Y.;Endo,H.;Sasaki,H.;Okytomi,T.;Saehi,T.;Tamura,G.J.Antibiot.1978,31,533.
[4]Wat,C.K.;Mc Innes,A.G.;Smith,D.G.;Wright,J.L.C.;Vining,L.C.Can.J.Chem.1997,55,4090.
[5]Alfatafta,A.A.;Gloer,J.B.;Scott,J.A.;Malloch,D.J.Nat.Prod.1994,57,1696.
[6]Kohno,J.;Hirano,N.;Sugawara,K.;Nishio,M.;Hashiyama,T.;Nakanishi,N.;Komatsubara,S.Tetrahedron 2001,57,1731.
[7]Jayasinghe,L.;Abbas,H.K.;Jacob,M.R.;Herath,W.H.M.W.;Nanayakkara,N.P.D.J.Nat.Prod.2006,69,439.
[8]Zhan,J.;Burns,A.M.;Liu,M.X.;Faeth,S.H.;Gunatilaka,A.A.L.J.Nat.Prod.2007,70,227.
[9]Silva,E.D.;Geiermann,A.S.;Mitova,M.I.;Kuegler,P.;Blunt,J.W.;Cole,A.L.J.;Munro,M.H.J.Nat.Prod.2009,72,477.
[10]Tsuchinari,M.;Shimanuki,K.;Hiramatsu,F.;Muratama,T.;Koseki,T.;Shiono,Y.Z.Naturforsch.,B:Chem.Sci.2007,62,1203.
[11]Hayakawa,S.;Minato,H.;Katagori,K.J.Antibiot.1971,24,653.
[12]Matsumoto,M.;Minato,H.Tetrahedron Lett.1976,42,3827.
[13]Gutierrez-Cirlos,E.B.;Merbitz-Zahradnik,T.;Trumpower,B.L.J.Biol.Chem.2004,279,8708.
[14]Bergmann,S.;Schumann,J.;Scherlach,K.;Lange,C.;Brakhage,A.A.;Hertweck,C.Nat.Chem.Biol.2007,3,213.
[15]Wasil,Z.;Pahirulzaman,K.A.K.;Butts,C.;Simpson,T.J.;Lazarus,C.M.;Cox,R.J.Chem.Sci.2013,4,3845.
[16]Fujimoto,H.;Ikeda,M.;Yamamoto,K.;Yamazaki,M.J.Nat.Prod.1993,56,1268.
[17]Amini,S.K.J.Struct.Chem.2015,56,1334.
[18]Sch?ffski,P.Anticancer Drugs 2004,15,85.
[19]Subissi,A.;Monti,D.;Togni,G.;Mailland,F.Drugs 2010,70,2133.
[20]Schmidt,K.;Reise,U.;Li,Z.;Hamburger,M.J.Nat.Prod.2003,66,378.
[21]Cheng,Y.;Schneider,B.;Reise,U.;Schubert,B.;Li,Z.;Hamburger,M.J.Nat.Prod.2006,69,436.
[22]Zhao,S.Y.;Huang,J.;Cheng,J.;Liu,B,S.;Chen,C.Chin.J.Org.Chem.2012,32,651(in Chinese).(赵圣印,黄婧,程健,刘宝硕,陈晨,有机化学,2012,32,651.)
[23]Ding,F.;Leow,M.L.;Ma,J.;William,R.;Liao,H.;Liu,X.-W.Chem.-Asian J.2014,9,2548.
[24]Ding,F.;William,R.;Leow,M.L.;Chai,H.;Fong,J.Z.M.;Liu,X.-W.Org.Lett.2014,16,26.
[25]Wan,J.-P.;Gao,Y.Chem.Rec.2016,16,1164.
[26]Wan,J.-P.;Zhong,S.;Guo,Y.;Wei,L.Eur.J.Org.Chem.2017,4401.
[27]Xu,D.-Q.;Xia,H.-B.;Luo,S.-P.;Tang,J.;Zhang,S.;Jiang,J.-R.;Xu,Z.-Y.Angew.Chem.,Int.Ed.2009,48,3821.
[28]Wan,J.-P.;Jing,Y.;Wei,L.Asian J.Org.Chem.2017,6,666.
[29]Guo,Y.;Zhong,S.;Wei,L.;Wan,J.-P.Beilstein J.Org.Chem.2017,13,2017.
[30]List,B.Acc.Chem.Res.2004,37,548.
[31]List,B.;Mukherjee,S.;Yang,J.W.;Hoffmann,S.Chem.Rev.2007,107,5471.
[32]Notz,W.;Tanaka,F.;Barbas,C.F.III.Acc.Chem.Res.2004,37,580.
[33]Wang,H.;Li,L.;Lin,W.;Huang,Z.;Shi,D.Chin.J.Org.Chem.2013,33,1616(in Chinese).(汪辉员,李丽丽,林伟,黄志斌,史达清,有机化学,2013,33,1616.)
[34]Stanovnik,B.;Groselj,U.Adv.Heterocycl.Chem.2010,100,145.
[35]Satheesh,M.;Balachandran,A.L.;Devi,P.R.;Deepthi,A.Synth.Commun.2018,48,582.
[36]Platts,M.Y.;Barber,C.G.;Chiva,J.Y.;Eastwood,R.L.;Fenwick,D.R.;Paradowski,K.A.;Blakemore,D.C.Tetrahedron Lett.2011,52,512.
[37]Zupancic,S.;Svete,J.;Stanovnik,B.Acta Chim.Slovoca 2008,55,1009.
[38]Zou,J.;Zhu,L.G.;Yu,Q.S.;Lin,R.S.Chemistry 1999,(13),2(in Chinese).(邹建卫,朱龙观,俞庆森,林瑞森,化学通报,1999,(13),2.)
[39]Bodor,N.;Dewar,M.J.S.;Harget,A.J.J.Am.Chem.Soc.1970,92,2929.
[40]Schlegel,H.B.Int.J.Quantum Chem.1982,22,1041.
[41]Baskovc,J.;Dahmann,G.;Golobic,A.;Groselj,U.;Kocar,D.;Stanovnik,B.;Svete,J.ACS Comb.Sci.2012,14,513.